Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) traded down 7.1% during trading on Friday . The stock traded as low as $1.05 and last traded at $1.05. 143,042 shares were traded during trading, a decline of 91% from the average session volume of 1,661,006 shares. The stock had previously closed at $1.13.
Silo Pharma Trading Down 7.1 %
The firm has a 50-day moving average of $1.12 and a 200 day moving average of $1.44.
Silo Pharma (NASDAQ:SILO – Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The company reported ($0.31) EPS for the quarter. Silo Pharma had a negative net margin of 4,881.57% and a negative return on equity of 55.30%. The company had revenue of $0.02 million for the quarter.
About Silo Pharma
Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.
Further Reading
- Five stocks we like better than Silo Pharma
- When to Sell a Stock for Profit or Loss
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Best Stocks Under $10.00
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Insider Buying Explained: What Investors Need to Know
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
